How is the Bio-Path Holdings Inc today?

The Bio-Path Holdings Inc today is trading in the down by 0.00% at 0.18.

What is Bio-Path Holdings Inc Annual Net Profit?

Bio-Path Holdings Inc Annual Net Profit rose 38.46% in the last year to $9.89 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Bio-Path Holdings Inc Price to Earning Ratio?

Bio-Path Holdings Inc Price to Earning Ratio is -0.16, which is negative.

What is Bio-Path Holdings Inc Stock Price?

Bio-Path Holdings Inc Stock Price fell 91.13% and underperformed its sector by 110.46% in the past year.

What is Bio-Path Holdings Inc Quarterly Net profit?

Bio-Path Holdings Inc Quarterly Net profit rose 9.66% YoY to $2.85 M. Its sector's average net profit growth YoY for the quarter was -213.06%.

What is Bio-Path Holdings Inc Debt to Equity Ratio?

Bio-Path Holdings Inc Debt to Equity Ratio of 0.54 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Bio-Path Holdings Inc Return on Equity(ROE)?

Bio-Path Holdings Inc Return on Equity(ROE) for the last financial year was -3,325.71%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Bio-Path Holdings Inc Mutual Fund Holding?

Bio-Path Holdings Inc Mutual Fund Holding decreased by 0.41% in the last quarter to 0.95.

What is Bio-Path Holdings Inc Promoter Share Holding?

Bio-Path Holdings Inc Promoter Share Holding stayed the same in the most recent quarter at 184.03%.

What is Bio-Path Holdings Inc Institutional Holding?

Bio-Path Holdings Inc Institutional Holding decreased by 2.82% in the last quarter to 0.9.

Bio-Path Holdings Inc XNAS: BPTH

Bio-Path Holdings Inc Live Share Price Today, Share Analysis and Chart

Name: Bio-Path Holdings Inc: Is Infosys Ltd. worth buying?
Item: Bio-Path Holdings Inc
Rating: 0.95350
Author: Trendlyne DVM scores

about

Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene p...

0.18 0.00 (0.00%)

96.04% Fall from 52W High

31,556 XNAS Volume

XNAS 16 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

2.0 / 100

Technically Neutral

36.1 / 100

No estimates available

Bio-Path Holdings Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Bio-Path Holdings Inc FAQ

How is Bio-Path Holdings Inc today?

Bio-Path Holdings Inc today is trading in the red, and is down by 0.00% at 0.18.

How has Bio-Path Holdings Inc performed historically?

Bio-Path Holdings Inc is currently trading down 0.00% on an intraday basis. In the past week the stock fell None%. stock has been down 0.00% in the past quarter and fell -91.13% in the past year. You can view this in the overview section.